Eversept Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Eversept Partners's PACB Position: Q3 2026 in Review
Eversept Partners opened a new position in Pacific Biosciences (PACB) in Q3 2026: 228,007 shares worth $540K. The stake represents 0.03% of the portfolio and ranks #102 among its holdings.
204 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Eversept Partners held 228,007 shares of Pacific Biosciences worth $540K as of Q3 2026.
- Pacific Biosciences was a new Eversept Partners position in Q3 2026.
- Pacific Biosciences made up 0.03% of Eversept Partners's portfolio in Q3 2026, its #102 holding.
- 204 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.